Oblique
      News
      Oblique Therapeutics is pleased to announce the nomination of Christer Nordstedt M.D. Ph.D. as Chief Executive Officer

      Oblique Therapeutics AB (publ.) is pleased to announce the confirmation of Christer Nordstedt MD.PhD. as Chief Executive Officer (CEO).

      Christer Nordstedt will assume the position on 1st December 2022.

      To learn more about this news, click on the link below:

      New CEO appointment Oblique Therapeutics AB November 2022